Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Colchicin, Atc M04ac01 For The Time 01.08.2025 - 31.07.2027 (plus Extension Option 1x12 Months) 2025-12-13
Germany Open House Pharmaceuticals Budesonide, Atc A07ea06 2025-12-13
Bulgaria Delivery Of Medical Supplies 2025-12-13
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2025-12-13
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Certolizumab Pegol, Atc L04ab05 For The Period 01.08.2025 31.07.2027 2025-12-13
Germany Completion Of A Non -exclusive Discount Contract According To § 130a Para. 8 Sgb V To Medicines With The Active Ingredient Iron (iii) Derisomalosis (atccode 2025-12-13
Germany Completion Of A Non -exclusive Discount Contract According To § 130a Para. 8 Sgb V To Drugs With The Active Ingredient Rituximab, Except Recipes (l01fa01). 2025-12-13
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Melatonin (exclusively 1mg And 5mg), Atc N05ch01 For The Period 01.08.2025 31.07.2027 2025-12-13
Germany Open House Pharmaceutical Department Treaties Tolvaptan, Except Medicines With Uniform Effects, Atc G04bx21 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Certolizumab Pegol, Atc L04ab05 For The Period 01.08.2025 - 31.07.2027 2025-12-13
Whats app